| Your Source for the Latest Patent Information |
User Functions Categories- All
- Announcements (5)
- In The News (609)
- OG Notice Links (306)
- Patents of the Day (468)
Archives- December 2007 (18)
- November 2007 (36)
- October 2007 (45)
- September 2007 (36)
- August 2007 (36)
- July 2007 (44)
- June 2007 (36)
- May 2007 (45)
- April 2007 (36)
- March 2007 (36)
- February 2007 (39)
- January 2007 (44)
- more...
Search Syndication Credits- powered by b2evo
- skin cloned from Movable Type
|
GEN-ERIC Patent News
Your Source for the Latest Patent Information
09/13/05
6,942,569 Drawing for winners over the internet using receipts and zipcodes  09/13/05
6,944,770 Methods and systems for generating and validating value-bearing documents  09/13/05
6,942,538 Inflatable humanoid forms  09/13/05
Symbol Technologies, Inc., The Enterprise Mobility Company(TM), today announced that the Court of Appeals for the Federal Circuit has affirmed the Nevada District Court's favorable decision in Symbol's patent lawsuit against the Lemelson Foundation. On Friday, September 9, the Appeals Court published its decision, holding that the Lemelson Foundation's patents at issue in this case are not enforceable. Posted by GEN-ERIC at 12:05:53 am into the following categories: In The News09/13/05
U.S. business software maker ePlus is suing its biggest rival, Germany's SAP, claiming infringement of three of its software patents, SAP said Wednesday, confirming a German magazine report. A representative for SAP, which denies the allegations, said the case had been filed in the U.S. District Court in Richmond, Va., in April and was due to be heard next March. The SAP representative declined to comment on how much ePlus was seeking in damages, and business weekly WirtschaftsWoche said in a release ahead of publication that ePlus had also declined to comment on the size of the claim. The SAP representative said: "On June 15, 2005, SAP filed an answer and counterclaims alleging that it does not infringe the ePlus patents and that the ePlus patents are invalid." The patents concerned are for software used to source goods electronically. Previous Next Earlier this year, ePlus accepted $37 million in settlement of a patent lawsuit it had filed against fellow U.S. business software maker Ariba. Posted by GEN-ERIC at 12:04:24 am into the following categories: In The News09/13/05
Solomon Technologies, Inc. announced today that it has filed an action against Toyota Motor Corporation in federal district court in Tampa, Florida for infringement of Solomon's Electric Wheel(R) patent. Solomon alleges that the hybrid transmission drive in the Toyota Prius and Highlander infringes a number of claims contained in its U.S. Patent No. 5,067,932. In the lawsuit Solomon is asking for an injunction barring further infringement as well as damages for the unauthorized use of its patent by Toyota. Solomon President Peter DeVecchis said, "We commenced this lawsuit based on extensive review and research including a thorough review by our special patent counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., of the basis of our claims. In determining this course of action we examined an existing Toyota Prius transmission against our patent claims." Mr. DeVecchis further stated, "While we are aware of the difficulties faced by a small company seeking to protect its patent rights against a large company like Toyota, we are determined to use every effort to realize for our shareholders the benefits from our patented technology." Posted by GEN-ERIC at 12:02:49 am into the following categories: In The News09/13/05
Competitive Technologies, Inc. (AMEX: CTT) announced that it had filed a complaint against Carolina Liquid Chemistries Corporation ("Carolina Liquid") of Brea, California, alleging patent infringement of CTT's U.S. Patent Number 4,940,658 covering homocysteine assays. The complaint was filed in the United States District Court for the District of Colorado. In the complaint, CTT seeks monetary damages, punitive damages, attorneys' fees, court costs and other remuneration at the option of the court. The homocysteine patent was derived from discoveries made by CTT's clients Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University. "The filing of this complaint is part of our comprehensive and ongoing monitoring program to protect the patent rights of ourselves, our clients, and our current homocysteine licensees," said Aris D. Despo, CTT's Senior Vice President, Life Sciences. "While we believe that we already have licensed the majority of laboratories, distributors and other users of homocysteine assay tests in the Unites States, we continue our diligence in seeking those who use or sell tests without a license." Posted by GEN-ERIC at 12:01:40 am into the following categories: In The News
|
Calendar| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | ||
LinksEmployment
USPTO
